Anuncio
relacionado con: johnson & johnson newsWe are building a world where solutions are personal. Learn more. We are uniquely positioned to innovate across the full spectrum of healthcare solutions.
- Latest news
See the latest news from J&J.
Company updates and more.
- Our leadership team
Meet the J&J Executive Committee
& our Board of Directors.
- The J&J Credo
Putting the needs of the
people we serve first.
- Discover J&J
Learn about our strength
in healthcare innovation.
- Latest news
Resultado de búsqueda
10 de oct. de 2024 · A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
12 de nov. de 2021 · Johnson & Johnson would Remain a Global Leader in Healthcare, Focused on Major Unmet Medical Needs and Materially Advancing Standard of Care through Biopharmaceutical and Medical Device Innovation and Technology.
Hace 5 días · Explore all Johnson & Johnson published press releases by date and/or topic of news.
23 de ene. de 2024 · 2023 Fourth-Quarter reported sales growth of 7.3% to $21.4 Billion with operational growth of 7.2%* and adjusted operational growth of 5.7%*. Operational growth excluding COVID-19 Vaccine of 10.9%*. 2023 Fourth-Quarter Earnings per share (EPS) of $1.70 increasing 39.3% and adjusted EPS of $2.29 increasing by 11.7%*.
News about Johnson & Johnson, including commentary and archival articles published in The New York Times.
5 de dic. de 2023 · At today’s meeting, members of Johnson & Johnson’s Executive Committee and leaders from the Innovative Medicine and MedTech businesses will highlight the Company’s key drivers for sustained competitive growth and value creation.
25 de feb. de 2021 · US regulators have found the single-shot Johnson & Johnson coronavirus vaccine is safe and effective. It paves the way for it to become the third Covid-19 vaccine to be authorised in the US,...
